Skip to main content

Month: May 2024

Plains All American Reports First-Quarter 2024 Results

Provides Update on Permian Long-Haul Contracting & Announces Bolt-on Acquisitions HOUSTON, May 03, 2024 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported first-quarter 2024 results and reaffirmed full-year 2024 Adjusted EBITDA guidance. Plains also provided updates on Permian long-haul contracting and announced two bolt-on acquisitions. First-Quarter ResultsReported Net income attributable to PAA of $266 million and Net cash provided by operating activities of $419 million Delivered Adjusted EBITDA attributable to PAA of $718 million; on-track to meet full-year guidance of $2.625 – $2.725 billion Generated Adjusted Free Cash Flow of $262 million (excluding changes in Assets & Liabilities; including bolt-on acquisition capital) Increased annualized...

Continue reading

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024

2024 OIS Retina and ARVO meetings are being held in Seattle, Washington BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, announced multiple presentations at the Ophthalmology Innovation Source (OIS) Retina 2024 (May 4th) and the Association for Research in Vision and Ophthalmology (ARVO) 2024 meetings (May 5-9th) being held in Seattle, Washington. Presentations at OIS Retina 2024:Session Title: “Spotlight on Drug Delivery”Session Date/Time: Saturday, May 4th, 11:15 AM – 12:00 PM PDTOcular Presentation:...

Continue reading

Kelly Enters Agreement to Acquire Specialty Talent Solutions Company, Motion Recruitment Partners, LLC

Transformational acquisition strengthens scale and capabilities of Kelly’s staffing and consulting solutions across technology, telecommunications, and government specialties in North America, and recruitment process outsourcing (RPO) solutions globally Provides Motion Recruitment Partners and its leading brands with a highly invested partner to enable continued growth Demonstrates Kelly’s commitment to rapidly redeploying capital and leveraging its strong balance sheet in pursuit of inorganic investments in higher-margin, higher-growth specialtiesTROY, Mich., May 03, 2024 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB) (“the Company”), a leading global specialty talent solutions provider, has entered into a definitive agreement to acquire Motion Recruitment Partners, LLC (“MRP”), from Littlejohn & Co., LLC (“Littlejohn”),...

Continue reading

Uniti Group Inc. Reports First Quarter 2024 Results

Announced Merger with Windstream Creates Premier Insurgent Fiber Provider Updates 2024 OutlookNet Income of $41.3 Million for the First Quarter Net Income of $0.16 Per Diluted Common Share for the First Quarter AFFO Per Diluted Common Share of $0.32 for the First QuarterLITTLE ROCK, Ark., May 03, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq: UNIT) today announced its results for the first quarter 2024. “Uniti is off to a solid start in 2024. Our core recurring strategic fiber business grew 4% in the first quarter of 2024 when compared to the first quarter of 2023. Also, our net success-based capital intensity at Uniti Fiber during the quarter declined to 34% from 46% in the first quarter of 2023. These metrics further reiterate that our lease-up strategy continues to be successful. We also continue...

Continue reading

TransAlta Reports First Quarter 2024 Results

CALGARY, Alberta, May 03, 2024 (GLOBE NEWSWIRE) — TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) today reported its financial results for the first quarter ended March 31, 2024, demonstrating strong operational and financial performance and reaffirming its 2024 outlook. First Quarter 2024 Financial Highlights TransAlta’s first quarter results exceeded our expectations given the anticipated decline in Alberta spot power prices to $99 per MWh in 2024, as compared to elevated spot power prices of $142 per MWh in 2023. The 30 per cent decline in spot prices year over year was primarily due to milder weather, lower natural gas prices and incremental generation from the addition of new wind and solar supply in the market. Highlights for the quarter include:Adjusted EBITDA(1) of $328 million, compared to...

Continue reading

TC Energy reports strong first quarter 2024 operating and financial results

Advancing clear set of strategic priorities to maximize shareholder returns CALGARY, Alberta, May 03, 2024 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) released its first quarter results today. François Poirier, TC Energy’s President and Chief Executive Officer commented, “During the first three months of 2024, we delivered 11 per cent year-over-year growth in comparable EBITDA1 and approximately four per cent growth in segmented earnings, which was underpinned by the continued reliability, availability, and exceptional performance of our assets.” Poirier continued, “Our clearly defined 2024 strategic priorities focused on maximizing the value of our assets, project execution and enhancing balance sheet strength remain unchanged as we progress throughout the year.” Highlights (All...

Continue reading

Chart Industries Reports First Quarter 2024 Financial Results

ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) (“Chart”) today reported results for the first quarter ended March 31, 2024. Results shown are from continuing operations. When referring to any comparative period, all metrics are pro forma for continuing operations of the combined business of Chart and Howden, unless noted otherwise. First quarter 2024 highlights compared to first quarter 2023, pro forma:Orders, backlog, sales, reported and adjusted gross margin, reported and adjusted operating margin, reported and adjusted EBITDA and associated EBITDA margin were all the highest in any first quarter in our history Orders of $1.12 billion, an increase of 4.3% which contributed to record backlog of $4.33 billion Sales of $950.7 million, an increase of 17.4%; pro forma organic growth of 18.3% net of...

Continue reading

Augmedix to Participate in Upcoming Investor Conferences in May and June 2024

SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) — Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024.RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat on May 15 at 10:30 a.m. ET, and be available for 1×1 investor meetings. The webcast link for the fireside chat can be found at https://ir.augmedix.com/. Benchmark Healthcare House Call Conference (Virtual): Management will be available for 1×1 investor meetings on May 21. B. Riley Annual Institutional Investor Conference (Beverly Hills, CA): Management will participate in a fireside chat on May 22 at 9:00 a.m. PT, and be available for 1×1 investor...

Continue reading

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024

CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. ET. A live webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.agios.com. A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation. About AgiosAgios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In the U.S., Agios markets a first-in-class...

Continue reading

Perspective Therapeutics to Participate at Upcoming May Investor Conferences

SEATTLE, May 03, 2024 (GLOBE NEWSWIRE) —  Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in the following upcoming investor conferences as scheduled below, and will be available for one-on-one meetings with investors. Guggenheim Healthcare Talks | Radiopharmaceuticals DayDate: Monday, May 13, 2024Location: New York, NY Format: Panel Discussion – Evolving Landscape of Radiopharmaceuticals in IndustryTime: Noon Format: Company PresentationTime: 2 p.m. ET 2024 RBC Capital Markets Global Healthcare ConferenceDate: Wednesday, May 15, 2024Location: New York, NYFormat: Fireside ChatTime: 9.30 a.m. ET Bank...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.